SMTP Compound for Renal Disease via Antioxidant Action
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for renal disease lack effective therapeutic or preventive options, particularly in addressing the underlying causes of oxidative stress and inflammation.
Innovation Solution
A drug containing a compound represented by Formula (I) is administered, which has been shown to have antioxidant and anti-inflammatory actions, thereby exerting a therapeutic or preventive effect on renal disease.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for renal disease are used, then current standard therapy is maintained, but therapeutic or preventive effect on underlying causes (oxidative stress and inflammation) is insufficient
Solution Approach 1:
The patent applies this principle by using SMTP compounds that naturally inhibit oxidative stress and inflammation (harmful factors) to convert these harmful effects into beneficial therapeutic outcomes. The compound transforms the harmful oxidative stress and inflammation into controlled, reduced states, thereby achieving therapeutic effect without simply masking symptoms.
Solution Approach 2:
The patent changes the chemical and biological parameters of the treatment approach by introducing SMTP compounds with specific molecular structures ( Formula I) that have different pharmacological properties from conventional treatments. This parameter change enables the treatment to directly address oxidative stress and inflammation, improving therapeutic reliability.
2Reliability
If no effective treatment targets oxidative stress and inflammation, then current treatment limitations are maintained, but progression of renal disease continues
Solution Approach 1:
The patent applies preliminary action by administering SMTP compounds before significant renal function loss occurs. The compound proactively inhibits oxidative stress and inflammation, preventing the progression of renal disease rather than merely treating symptoms after damage has occurred. This extends the duration of renal function preservation.
Solution Approach 2:
By converting harmful oxidative stress and inflammation into controlled states through SMTP compound treatment, the patent achieves preventive effect that preserves renal function over time, transforming a harmful progression trajectory into a beneficial stabilization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The drug effectively inhibits the progression of renal disease by reducing oxidative stress and inflammation, as demonstrated by improved renal function parameters in animal models.
Implementation Method 1
it has been confirmed that the compound described above has an antioxidant action
Implementation Method 2
it is presumed that the action on renal disease is also based on a combination of anti-inflammatory action and antioxidative action
Data Source
AI summary
A drug for renal disease, the drug including a compound represented by the following Formula (I) as an active ingredient.